Astrazeneca reported $15.57B in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
AstraZeneca AZN:LN 15567M 7931M
Astrazeneca AZN:US $ 15567M 7931M
Bristol Myers Squibb BMY:US $ 11024M 42M
Canopy Growth Corp WEED:CN C$ 192.56M 525.51M
Catalent CTLT:US $ 896M 92.1M
Corcept Therapeutics CORT:US $ 95.43M 43.05M
Drreddys Laboratories RDY:US $ 360M 144M
Eli Lilly And LLY:US $ 3220M 217.6M
Endo International Ordinary Shares ENDP:US $ 1545.17M 117.4M
Genmab GEN:DC DK 9477M 1585M
GlaxoSmithKline GSK:LN 3503M 1254M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Horizon Pharma HZNP:US $ 812.32M 0.71M
Lannett LCI:US $ 93.29M 12M
Novartis NOVN:VX SF 5117M 1316M
Pacira Pharmaceuticals PCRX:US $ 105.77M 39.08M
Perrigo Ordinary Shares PRGO:US $ 317.5M 153.4M
Phibro Animal Health PAHC:US $ 50.21M 1.11M
Prestige Brands PBH:US $ 163.62M 131.32M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
Teva Pharmaceutical Industries TEVA:US $ 2436M 693M
Valeant Pharmaceuticals VRX:CN $ 642M 37M
Zoetis ZTS:US $ 3657M 57M